Raffy Kazandjian
Director/Board Member bij GENOWAY
Profiel
Mr. Raffy Kazandjian is a Manager at Euromedical Instruments SARL and a Venture Partner at Equitis Gestion SAS.
He is on the Board of Directors at genOway SA. Mr. Kazandjian was previously employed as a Partner by Innovation Capital SASU and a Chairman by Meiogenix SAS.
He also served on the board at Cellectis SA, Eyevensys SAS and Oralance Pharma SA. He received his undergraduate degree from École Nationale Supérieure de Chimie de Paris, a graduate degree from Massachusetts Institute of Technology and an MBA from INSEAD.
Actieve functies van Raffy Kazandjian
Bedrijven | Functie | Begin |
---|---|---|
GENOWAY | Director/Board Member | - |
Equitis Gestion SAS
Equitis Gestion SAS Investment ManagersFinance Equitis Gestion SAS is an independent private equity service and investment management firm established in 2000 and located in Paris. Equitis manages private equity funds including venture capital and regional funds. The firm also manages private equity funds and portfolios for third parties, typically for large financial groups. Equitis provides a range of services to private equity investors, including company valuation, business plan audit, and secondary sale organization. Their clients are financial institutions, family trusts and corporations in France and abroad. | Private Equity Analyst | - |
Euromedical Instruments SARL
Euromedical Instruments SARL Wholesale DistributorsDistribution Services Euromedical Instruments SARL distributes surgical radio-guided detection probes to surgeons and nuclear physicians. It comprises Europrobe3 read-out module which is fitted with a wide range of probes in order to address different clinical needs. The company was founded in 2000 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
Eerdere bekende functies van Raffy Kazandjian
Bedrijven | Functie | Einde |
---|---|---|
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Director/Board Member | - |
Innovation Capital SASU
Innovation Capital SASU Investment ManagersFinance Innovation Capital SASU (Innovation Capital) is the international venture capital subsidiary of CDC Capital Investissement SAS, itself a wholly-owned subsidiary of State-owned CDC Caisse des Dépôts et Consignations in France. Established in 1996 as CDC Entreprises Innovation, the firm was formerly known as CDC Innovation SASU. They changed their name to Innovation Capital SASU in 2012. Located in Paris with representative offices in California and in Switzerland, the firm manages venture capital and innovation mutual funds (FCPRs and FCPIs). Their venture capital funds are sponsored by CDC Capital Investissement, and the innovation funds are generally co-invested with the venture capital funds. The firm's mandate includes public interest missions. | Corporate Officer/Principal | - |
Oralance Pharma SA
Oralance Pharma SA Pharmaceuticals: MajorHealth Technology Oralance Pharma SA designs and develops oral forms of drug molecules. The company focuses on the development of new oral drug delivery systems protected by worldwide patents and providing API's stabilisation, gastroprotection, gastroresistance, taste masking and enhanced bioavailability. Oralance Pharma was founded in 2003 and is headquartered in Paris, France. | Director/Board Member | - |
Meiogenix SAS
Meiogenix SAS BiotechnologyHealth Technology Meiogenix SAS operates as a biotech company which develops breeding technologies. Its technology allows the modulation of the homologous recombination in eukaryotic cells. It facilitates the natural process that introduces genetic diversity in organisms allowing the generation of novel natural varieties. The company was founded by Giacomo Bastianelli and Alain Nicolas in 2011 and is headquartered in Paris, France. | Chairman | - |
CELLECTIS S.A. | Director/Board Member | - |
Opleiding van Raffy Kazandjian
Massachusetts Institute of Technology | Graduate Degree |
INSEAD | Masters Business Admin |
École Nationale Supérieure de Chimie de Paris | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
GENOWAY | Health Technology |
CELLECTIS S.A. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Innovation Capital SASU
Innovation Capital SASU Investment ManagersFinance Innovation Capital SASU (Innovation Capital) is the international venture capital subsidiary of CDC Capital Investissement SAS, itself a wholly-owned subsidiary of State-owned CDC Caisse des Dépôts et Consignations in France. Established in 1996 as CDC Entreprises Innovation, the firm was formerly known as CDC Innovation SASU. They changed their name to Innovation Capital SASU in 2012. Located in Paris with representative offices in California and in Switzerland, the firm manages venture capital and innovation mutual funds (FCPRs and FCPIs). Their venture capital funds are sponsored by CDC Capital Investissement, and the innovation funds are generally co-invested with the venture capital funds. The firm's mandate includes public interest missions. | Finance |
Oralance Pharma SA
Oralance Pharma SA Pharmaceuticals: MajorHealth Technology Oralance Pharma SA designs and develops oral forms of drug molecules. The company focuses on the development of new oral drug delivery systems protected by worldwide patents and providing API's stabilisation, gastroprotection, gastroresistance, taste masking and enhanced bioavailability. Oralance Pharma was founded in 2003 and is headquartered in Paris, France. | Health Technology |
Equitis Gestion SAS
Equitis Gestion SAS Investment ManagersFinance Equitis Gestion SAS is an independent private equity service and investment management firm established in 2000 and located in Paris. Equitis manages private equity funds including venture capital and regional funds. The firm also manages private equity funds and portfolios for third parties, typically for large financial groups. Equitis provides a range of services to private equity investors, including company valuation, business plan audit, and secondary sale organization. Their clients are financial institutions, family trusts and corporations in France and abroad. | Finance |
Meiogenix SAS
Meiogenix SAS BiotechnologyHealth Technology Meiogenix SAS operates as a biotech company which develops breeding technologies. Its technology allows the modulation of the homologous recombination in eukaryotic cells. It facilitates the natural process that introduces genetic diversity in organisms allowing the generation of novel natural varieties. The company was founded by Giacomo Bastianelli and Alain Nicolas in 2011 and is headquartered in Paris, France. | Health Technology |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Commercial Services |
Euromedical Instruments SARL
Euromedical Instruments SARL Wholesale DistributorsDistribution Services Euromedical Instruments SARL distributes surgical radio-guided detection probes to surgeons and nuclear physicians. It comprises Europrobe3 read-out module which is fitted with a wide range of probes in order to address different clinical needs. The company was founded in 2000 and is headquartered in Paris, France. | Distribution Services |